CVS Health (CVS) needs to shed its image as a health care stock to move ahead, said TheStreet's Jim Cramer. The pharmacy and retailer is slated to report 2016 third-quarter results before Tuesday's opening bell. Wall Street is expecting earnings and revenue to rise year over year during the quarter. Analysts surveyed by FactSet are looking for adjusted earnings of $1.57 per share on revenue of $45.3 billion. During the same period in 2015, Woonsocket, R.I.-based CVS posted adjusted earnings of $1.28 per share on revenue of $38.6 billion. Additionally, CVS announced yesterday that it's planning to cut 600 corporate jobs in Rhode Island, Illinois and Arizona over the next two months.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.